Iconic Labs Plc Logo

Iconic Labs Plc

ICON.L

(1.2)
Stock Price

5,25 GBp

-3.12% ROA

0.01% ROE

-1.23x PER

Market Cap.

585.979,00 GBp

-66.64% DER

0% Yield

0% NPM

Iconic Labs Plc Stock Analysis

Iconic Labs Plc Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Iconic Labs Plc Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (-642.28x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a low debt to equity ratio (-53%), which means it has a small amount of debt compared to the ownership it holds

3 ROE

The stock's ROE falls within an average range (12.12%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (-1516.84%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

5 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

6 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

7 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Iconic Labs Plc Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Iconic Labs Plc Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

Iconic Labs Plc Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Iconic Labs Plc Revenue
Year Revenue Growth
2013 4.522
2014 118.311 96.18%
2015 50.644 -133.61%
2016 50.765 0.24%
2016 25.000 -103.06%
2017 50.765 50.75%
2018 0 0%
2019 107.303 100%
2020 509.171 78.93%
2021 26.823 -1798.26%
2022 0 0%
2023 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Iconic Labs Plc Research and Development Expenses
Year Research and Development Expenses Growth
2013 0
2014 0 0%
2015 0 0%
2016 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Iconic Labs Plc General and Administrative Expenses
Year General and Administrative Expenses Growth
2013 0
2014 0 0%
2015 0 0%
2016 0 0%
2016 1.347.886 100%
2017 120 -1123138.33%
2018 218.601 99.95%
2019 846.076 74.16%
2020 1.965.643 56.96%
2021 248.152 -692.11%
2022 4.768.579 94.8%
2023 1.098 -434592.71%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Iconic Labs Plc EBITDA
Year EBITDA Growth
2013 -146.150
2014 -246.667 40.75%
2015 -221.661 -11.28%
2016 -2.676.272 91.72%
2016 -1.306.743 -104.8%
2017 -2.676.272 51.17%
2018 -218.320 -1125.85%
2019 -2.683.940 91.87%
2020 -7.690.497 65.1%
2021 -892.356 -761.82%
2022 0 0%
2023 2.957 100%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Iconic Labs Plc Gross Profit
Year Gross Profit Growth
2013 4.179
2014 109.222 96.17%
2015 50.543 -116.1%
2016 50.765 0.44%
2016 -1.212.828 104.19%
2017 -2.836.401 57.24%
2018 -278 -1020188.13%
2019 107.041 100.26%
2020 509.101 78.97%
2021 26.238 -1840.32%
2022 0 0%
2023 -778 100%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Iconic Labs Plc Net Profit
Year Net Profit Growth
2013 -87.501
2014 -191.659 54.35%
2015 -217.031 11.69%
2016 -2.808.853 92.27%
2016 -1.361.113 -106.36%
2017 -2.808.853 51.54%
2018 -4.173.616 32.7%
2019 -2.543.861 -64.07%
2020 -7.697.938 66.95%
2021 -762.107 -910.09%
2022 4.768.623 115.98%
2023 1.081 -441439.17%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Iconic Labs Plc Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2013 0
2014 0 0%
2015 0 0%
2016 0 0%
2016 0 0%
2017 0 0%
2018 -149 100%
2019 -10 -1390%
2020 0 0%
2021 0 0%
2022 1 100%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Iconic Labs Plc Free Cashflow
Year Free Cashflow Growth
2013 -100.083
2014 -231.330 56.74%
2015 -240.981 4%
2016 -905.937 73.4%
2016 -616.204 -47.02%
2017 -2.464.816 75%
2018 -4.090.663 39.75%
2019 -1.642.255 -149.09%
2020 1.154.721 242.22%
2021 -50.924 2367.54%
2022 -919.762 94.46%
2023 -564 -163268.03%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Iconic Labs Plc Operating Cashflow
Year Operating Cashflow Growth
2013 -98.655
2014 -179.369 45%
2015 -240.981 25.57%
2016 -700.406 65.59%
2016 -535.207 -30.87%
2017 -2.140.827 75%
2018 -4.083.153 47.57%
2019 -1.602.655 -154.77%
2020 1.154.721 238.79%
2021 -50.924 2367.54%
2022 -919.762 94.46%
2023 -564 -163268.03%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Iconic Labs Plc Capital Expenditure
Year Capital Expenditure Growth
2013 1.428
2014 51.961 97.25%
2015 0 0%
2016 205.531 100%
2016 80.997 -153.75%
2017 323.989 75%
2018 7.510 -4214.1%
2019 39.600 81.04%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Iconic Labs Plc Equity
Year Equity Growth
2013 -55.287
2014 -222.268 75.13%
2015 -494.408 55.04%
2016 812.233 160.87%
2017 -568.776 242.8%
2018 -1.817.113 68.7%
2019 -3.112.666 41.62%
2020 -8.176.413 61.93%
2021 -8.938.520 8.53%
2022 -3.639.897 -145.57%
2023 -2.742.329 -32.73%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Iconic Labs Plc Assets
Year Assets Growth
2013 27.322
2014 112.882 75.8%
2015 98.556 -14.54%
2016 1.616.684 93.9%
2017 1.432.020 -12.9%
2018 38.612 -3608.74%
2019 360.722 89.3%
2020 154.056 -134.15%
2021 6 -2567500%
2022 50.244 99.99%
2023 14.175 -254.46%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Iconic Labs Plc Liabilities
Year Liabilities Growth
2013 82.609
2014 335.150 75.35%
2015 592.964 43.48%
2016 804.451 26.29%
2017 2.000.796 59.79%
2018 1.855.725 -7.82%
2019 3.473.388 46.57%
2020 8.330.469 58.31%
2021 8.938.526 6.8%
2022 3.690.141 -142.23%
2023 2.756.504 -33.87%

Iconic Labs Plc Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.04
Price to Earning Ratio
-1.23x
Price To Sales Ratio
0x
POCF Ratio
-0.27
PFCF Ratio
-297.21
Price to Book Ratio
-0
EV to Sales
0
EV Over EBITDA
-446.7
EV to Operating CashFlow
-1223.49
EV to FreeCashFlow
-1223.49
Earnings Yield
-0.82
FreeCashFlow Yield
-0
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
16.02
Graham NetNet
-266.41

Income Statement Metrics

Net Income per Share
-0.04
Income Quality
4.46
ROE
0
Return On Assets
-0.03
Return On Capital Employed
-0
Net Income per EBT
1
EBT Per Ebit
-0.09
Ebit per Revenue
0
Effective Tax Rate
12.23

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.19
Free CashFlow per Share
-0.19
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.06
Return on Tangible Assets
-0.03
Days Sales Outstanding
0
Days Payables Outstanding
1629092.25
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,11
Book Value per Share
-266,09
Tangible Book Value per Share
-266.09
Shareholders Equity per Share
-266.09
Interest Debt per Share
177.31
Debt to Equity
-0.67
Debt to Assets
128.92
Net Debt to EBITDA
-338.19
Current Ratio
0.01
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-0.67
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
3.12

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Iconic Labs Plc Dividends
Year Dividends Growth

Iconic Labs Plc Profile

About Iconic Labs Plc

Iconic Labs Plc engages in media and technology business, focuses providing online marketing, and content and technology driven products. It also engages in digital and social media publishing activities. The company offers advisory services to clients on their businesses; and delivers campaigns, as well as provides creative services to its clients. Its activities include monthly insights, content creation and distribution, post campaign analysis, and combining with online media brands. The company was formerly known as WideCells Group PLC and changed its name to Iconic Labs Plc in July 2019. Iconic Labs Plc was founded in 2012 and is based in London, the United Kingdom.

CEO
Mr. Bradley Taylor
Employee
3
Address
Waverley House
London, W1F 8GQ

Iconic Labs Plc Executives & BODs

Iconic Labs Plc Executives & BODs
# Name Age
1 Mr. Bradley Taylor
Chairman, Chief Operating Officer, Chief Executive Officer & Executive Director
70
2 Dr. Peter Hollands
Director of WideCells Storage and Research Division & Group's Chief Scientific Officer
70

Iconic Labs Plc Competitors